APA (7th ed.) Citation

A, C., J, G., S, T., EB, C., U, M., J, V. D., . . . B, H. (2026). Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: The SHARP-P study. The International journal on drug policy, 151, 105234. https://doi.org/10.1016/j.drugpo.2026.105234

Chicago Style (17th ed.) Citation

A, Conway, et al. "Reinfection Following Direct-acting Antiviral Therapy for Hepatitis C Infection Among People in Prison with Recent Injecting Drug Use: The SHARP-P Study." The International Journal on Drug Policy 151 (2026): 105234. https://doi.org/10.1016/j.drugpo.2026.105234.

MLA (9th ed.) Citation

A, Conway, et al. "Reinfection Following Direct-acting Antiviral Therapy for Hepatitis C Infection Among People in Prison with Recent Injecting Drug Use: The SHARP-P Study." The International Journal on Drug Policy, vol. 151, 2026, p. 105234, https://doi.org/10.1016/j.drugpo.2026.105234.